Meeting
2014 ASCO Annual Meeting
Phase I study of preoperative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma.
Authors
Gopi Kesaria Prithviraj
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Gopi Kesaria Prithviraj , Kun Jiang , Xiuhua Zhao , Dung-Tsa Chen , Brian Morse , Ravi Shridhar , Sarah E. Hoffe , David Shibata , Richard D. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT01376453
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3636^)
DOI
10.1200/jco.2014.32.15_suppl.3636
Abstract #
3636^
Poster Bd #
99
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Preoperative infusional 5-FU and sorafenib with external radiation therapy in locally advanced rectal cancer: Results of a phase I study.
First Author: Gopi Kesaria Prithviraj
Poster
2020 Gastrointestinal Cancers Symposium
Phase I study of preoperative capecitabine and lenvatinib with external radiation therapy in locally advanced rectal adenocarcinoma.
First Author: Ankita Tandon
Poster
2012 ASCO Annual Meeting
Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients with locally advanced, K-ras-mutated rectal cancer (LARC): A phase I/II trial (SAKK 41/08).
First Author: Roger Von Moos
Poster
2012 Gastrointestinal Cancers Symposium
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial.
First Author: Prajnan Das